Cory Kasimov
Stock Analyst at Evercore ISI
(4.88)
# 311
Out of 4,516 analysts
993
Total ratings
59.3%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $535 | $477.08 | +12.14% | 60 | Jul 7, 2026 | |
| COAG Hemab Therapeutics Holdings | Initiated Coverage: Buy | $50 | $43.32 | +15.42% | 1 | May 26, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $120 | $58.95 | +103.56% | 83 | May 21, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $200 → $210 | $172.05 | +22.06% | 16 | May 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $875 → $825 | $664.45 | +24.16% | 77 | May 18, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 | $22.92 | +74.52% | 7 | May 13, 2026 | |
| BNTC Benitec Biopharma | Initiated Coverage: Buy | $25 | $13.02 | +92.01% | 1 | May 12, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $55 → $80 | $67.71 | +18.15% | 6 | May 8, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $65 | $54.04 | +20.28% | 1 | May 8, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $125 → $130 | $82.66 | +57.27% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $45 | $30.84 | +45.91% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $40.83 | +10.21% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $9.61 | +87.30% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $184.44 | +8.44% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $50 | $68.28 | -26.77% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $279.14 | +43.30% | 6 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $15.07 | +125.61% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $82.62 | -3.17% | 10 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $11.14 | +124.42% | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $7.27 | +106.33% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $29.41 | +87.01% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $91.99 | +41.32% | 31 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $128 | $31.71 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $84 | $16.03 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $51.98 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $219 → $221 | $197.24 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $25.92 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $3.55 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $20 | $1.90 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $19 → $16 | $3.04 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $235 → $227 | $358.32 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $98 → $86 | $115.09 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 | $23.04 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $17.05 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $131.70 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $8.41 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $87.51 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $44.65 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $0.5343 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $4.09 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $100 | $1,156.63 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280.92 | $6.85 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.0681 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.13 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $9.53 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $8.43 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $68 | $54.73 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $346.91 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $9.41 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.0001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $41.18 | n/a | 1 | Jun 4, 2013 |
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $535
Current: $477.08
Upside: +12.14%
Hemab Therapeutics Holdings
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $43.32
Upside: +15.42%
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $120
Current: $58.95
Upside: +103.56%
Neurocrine Biosciences
May 18, 2026
Maintained: Buy
Price Target: $200 → $210
Current: $172.05
Upside: +22.06%
Regeneron Pharmaceuticals
May 18, 2026
Maintained: Buy
Price Target: $875 → $825
Current: $664.45
Upside: +24.16%
Immunome
May 13, 2026
Maintained: Buy
Price Target: $40
Current: $22.92
Upside: +74.52%
Benitec Biopharma
May 12, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $13.02
Upside: +92.01%
Xenon Pharmaceuticals
May 8, 2026
Maintained: Buy
Price Target: $55 → $80
Current: $67.71
Upside: +18.15%
Scholar Rock Holding
May 8, 2026
Maintained: Buy
Price Target: $65
Current: $54.04
Upside: +20.28%
BridgeBio Pharma
May 8, 2026
Maintained: Buy
Price Target: $125 → $130
Current: $82.66
Upside: +57.27%
May 8, 2026
Maintained: Buy
Price Target: $35 → $45
Current: $30.84
Upside: +45.91%
May 8, 2026
Maintained: Buy
Price Target: $45
Current: $40.83
Upside: +10.21%
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $9.61
Upside: +87.30%
May 7, 2026
Maintained: Buy
Price Target: $200
Current: $184.44
Upside: +8.44%
May 4, 2026
Maintained: Hold
Price Target: $35 → $50
Current: $68.28
Upside: -26.77%
May 1, 2026
Reiterated: Buy
Price Target: $400
Current: $279.14
Upside: +43.30%
May 1, 2026
Maintained: Buy
Price Target: $34
Current: $15.07
Upside: +125.61%
Apr 1, 2026
Maintained: Buy
Price Target: $80
Current: $82.62
Upside: -3.17%
Apr 1, 2026
Maintained: Buy
Price Target: $25
Current: $11.14
Upside: +124.42%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $7.27
Upside: +106.33%
Mar 17, 2026
Maintained: Buy
Price Target: $55
Current: $29.41
Upside: +87.01%
Mar 11, 2026
Maintained: Buy
Price Target: $130
Current: $91.99
Upside: +41.32%
Jul 29, 2022
Maintained: Buy
Price Target: $126 → $128
Current: $31.71
Upside: n/a
Jul 28, 2022
Maintained: Hold
Price Target: $91 → $84
Current: $16.03
Upside: n/a
Jul 27, 2022
Maintained: Hold
Price Target: $30 → $33
Current: $51.98
Upside: n/a
Jul 20, 2022
Maintained: Hold
Price Target: $219 → $221
Current: $197.24
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $25.92
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $14 → $11
Current: $3.55
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $24 → $20
Current: $1.90
Upside: n/a
May 4, 2022
Maintained: Sell
Price Target: $19 → $16
Current: $3.04
Upside: n/a
Apr 28, 2022
Maintained: Hold
Price Target: $235 → $227
Current: $358.32
Upside: n/a
Feb 9, 2022
Maintained: Hold
Price Target: $98 → $86
Current: $115.09
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $61
Current: $23.04
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $17.05
Upside: n/a
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $131.70
Upside: n/a
Feb 25, 2021
Maintained: Sell
Price Target: n/a
Current: $8.41
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $87.51
Upside: n/a
Nov 13, 2019
Maintained: Buy
Price Target: n/a
Current: $44.65
Upside: n/a
Jun 26, 2018
Maintained: Sell
Price Target: n/a
Current: $0.5343
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $4.09
Upside: n/a
Apr 11, 2017
Maintained: Buy
Price Target: $384 → $100
Current: $1,156.63
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $280.92
Current: $6.85
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.0681
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $2.13
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $9.53
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $8.43
Upside: n/a
Jun 8, 2015
Maintained: Hold
Price Target: $65 → $68
Current: $54.73
Upside: n/a
Jan 13, 2015
Maintained: Hold
Price Target: n/a
Current: $346.91
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $9.41
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.0001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $41.18
Upside: n/a